cardiovascular-agents and Salmonella-Infections--Animal

cardiovascular-agents has been researched along with Salmonella-Infections--Animal* in 1 studies

Other Studies

1 other study(ies) available for cardiovascular-agents and Salmonella-Infections--Animal

ArticleYear
Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride.
    Microbiological research, 2003, Volume: 158, Issue:3

    Ten cardiovascular drugs, having diverse pharmacological action, were screened for possible antimicrobial property against known eight sensitive bacteria, belonging to Gram positive and Gram negative types. Although five drugs failed to show antimicrobial activity and three had moderate antimicrobial action, oxyfedrine HCl and dobutamine were seen to possess pronounced antimicrobial property. Oxyfedrine was further tested in vitro against 471 strains of bacteria from two Gram positive and fourteen Gram negative genera. The minimum inhibitory concentration (MIC) of oxyfedrine was determined by agar dilution method, which ranged from 50-200 microg/ml in most of the strains, while some strains were inhibited at even lower concentrations. In animal experiments, this compound was capable of offering significant protection to Swiss strain of white mice, challenged with 50 median lethal dose (MLD) of a virulent strain of Salmonella typhimurium at concentrations of 15, 30 and 60 microg/mouse. The in vivo results were highly significant according to chi-square test.

    Topics: Animals; Anti-Bacterial Agents; Cardiotonic Agents; Cardiovascular Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Oxyfedrine; Salmonella Infections, Animal; Salmonella typhimurium

2003